Chia-Chung Lee

546 total citations
24 papers, 494 citations indexed

About

Chia-Chung Lee is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Chia-Chung Lee has authored 24 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 12 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in Chia-Chung Lee's work include Synthesis and biological activity (10 papers), Bioactive Compounds and Antitumor Agents (8 papers) and Cancer therapeutics and mechanisms (8 papers). Chia-Chung Lee is often cited by papers focused on Synthesis and biological activity (10 papers), Bioactive Compounds and Antitumor Agents (8 papers) and Cancer therapeutics and mechanisms (8 papers). Chia-Chung Lee collaborates with scholars based in Taiwan, Singapore and Russia. Chia-Chung Lee's co-authors include Hsu‐Shan Huang, Tsung‐Chih Chen, Chun‐Liang Chen, Deh‐Ming Chang, Kuo-Feng Huang, Jing‐Jer Lin, Fei-Lan Liu, Jih‐Hwa Guh, Ahmed Ali and Dah‐Shyong Yü and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Chia-Chung Lee

24 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chia-Chung Lee Taiwan	16	298	196	114	108	39	24	494
Tsung‐Chih Chen Taiwan	16	328 1.1×	219 1.1×	125 1.1×	133 1.2×	49 1.3×	27	550
Marek Šarišský Slovakia	15	245 0.8×	129 0.7×	40 0.4×	49 0.5×	46 1.2×	25	530
Jin Yin China	11	301 1.0×	107 0.5×	76 0.7×	107 1.0×	26 0.7×	15	520
Chia-Ning Yang Taiwan	12	380 1.3×	274 1.4×	68 0.6×	158 1.5×	90 2.3×	14	668
Olivia Aranha United States	13	398 1.3×	129 0.7×	91 0.8×	213 2.0×	76 1.9×	34	676
Sung Yun Cho South Korea	15	356 1.2×	277 1.4×	43 0.4×	115 1.1×	32 0.8×	43	673
Mi Yan China	12	296 1.0×	393 2.0×	40 0.4×	65 0.6×	61 1.6×	21	866
Brian W. Fox United Kingdom	14	334 1.1×	268 1.4×	90 0.8×	171 1.6×	85 2.2×	35	721
Javier Rojas Spain	9	222 0.7×	221 1.1×	42 0.4×	212 2.0×	22 0.6×	13	599
Yali Deng China	9	479 1.6×	236 1.2×	43 0.4×	240 2.2×	73 1.9×	13	802

Countries citing papers authored by Chia-Chung Lee

Since Specialization

Citations

This map shows the geographic impact of Chia-Chung Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chia-Chung Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chia-Chung Lee more than expected).

Fields of papers citing papers by Chia-Chung Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chia-Chung Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chia-Chung Lee. The network helps show where Chia-Chung Lee may publish in the future.

Co-authorship network of co-authors of Chia-Chung Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Chia-Chung Lee. A scholar is included among the top collaborators of Chia-Chung Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chia-Chung Lee. Chia-Chung Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ho, Yi‐Jung, Jeng‐Wei Lu, Ling‐Jun Ho, et al.. (2019). Anti-inflammatory and anti-osteoarthritis effects of Cm-02 and Ck-02. Biochemical and Biophysical Research Communications. 517(1). 155–163. 11 indexed citations

Liu, Fei-Lan, Chun‐Liang Chen, Chia-Chung Lee, et al.. (2017). The Simultaneous Inhibitory Effect of Niclosamide on RANKL-Induced Osteoclast Formation and Osteoblast Differentiation. International Journal of Medical Sciences. 14(9). 840–852. 15 indexed citations

Ali, Ahmed, Yu-Ru Lee, Tsung‐Chih Chen, et al.. (2016). Novel Anthra[1,2-c][1,2,5]Thiadiazole-6,11-Diones as Promising Anticancer Lead Compounds: Biological Evaluation, Characterization & Molecular Targets Determination. PLoS ONE. 11(4). e0154278–e0154278. 16 indexed citations

Lee, Chia-Chung, Chun‐Liang Chen, Fei-Lan Liu, et al.. (2016). Development of 1‐Amino‐4‐(phenylamino)anthraquinone‐2‐sulfonate Sodium Derivatives as a New Class of Inhibitors of RANKL‐Induced Osteoclastogenesis. Archiv der Pharmazie. 349(5). 342–355. 5 indexed citations

Lee, Chia-Chung, Ling‐Jun Ho, Jenn-Haung Lai, et al.. (2016). A New Application of Parallel Synthesis Strategy for Discovery of Amide-Linked Small Molecules as Potent Chondroprotective Agents in TNF-α-Stimulated Chondrocytes. PLoS ONE. 11(3). e0149317–e0149317. 6 indexed citations

Lee, Chia-Chung, Fei-Lan Liu, Chun‐Liang Chen, et al.. (2015). Discovery of 5-(2′,4′-difluorophenyl)-salicylanilides as new inhibitors of receptor activator of NF-κB ligand (RANKL)-induced osteoclastogenesis. European Journal of Medicinal Chemistry. 98. 115–126. 32 indexed citations

Chen, Tsung‐Chih, Chun‐Liang Chen, Chia-Chung Lee, et al.. (2015). Identification of a new class of WNT1 inhibitor: Cancer cells migration, G-quadruplex stabilization and target validation. Oncotarget. 7(42). 67986–68001. 10 indexed citations

Lee, Chia-Chung, Fei-Lan Liu, Chun‐Liang Chen, et al.. (2015). Novel inhibitors of RANKL-induced osteoclastogenesis: Design, synthesis, and biological evaluation of 6-(2,4-difluorophenyl)-3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-diones. Bioorganic & Medicinal Chemistry. 23(15). 4522–4532. 22 indexed citations

Lee, Yu-Ru, Tsung‐Chih Chen, Chia-Chung Lee, et al.. (2015). Ring fusion strategy for synthesis and lead optimization of sulfur-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-dione derivatives as promising scaffold of antitumor agents. European Journal of Medicinal Chemistry. 102. 661–676. 30 indexed citations

10.

Hsu, Jui-Ling, Shih‐Ping Liu, Chia-Chung Lee, et al.. (2014). A unique amidoanthraquinone derivative displays antiproliferative activity against human hormone-refractory metastatic prostate cancers through activation of LKB1-AMPK-mTOR signaling pathway. Naunyn-Schmiedeberg s Archives of Pharmacology. 387(10). 979–990. 9 indexed citations

11.

Chen, Tsung‐Chih, et al.. (2014). Structure-based hybridization, synthesis and biological evaluation of novel tetracyclic heterocyclic azathioxanthone analogues as potential antitumor agents. European Journal of Medicinal Chemistry. 103. 615–627. 32 indexed citations

12.

Chen, Chun‐Liang, Fei-Lan Liu, Chia-Chung Lee, et al.. (2014). Ring fusion strategy for the synthesis of anthra[2,3-d]oxazole-2-thione-5,10-dione homologues as DNA topoisomerase inhibitors and as antitumor agents. European Journal of Medicinal Chemistry. 87. 30–38. 18 indexed citations

13.

Chen, Tsung‐Chih, Dah‐Shyong Yü, Kuo-Feng Huang, et al.. (2013). Structure-based design, synthesis and biological evaluation of novel anthra[1,2-d]imidazole-6,11-dione homologues as potential antitumor agents. European Journal of Medicinal Chemistry. 69. 278–293. 23 indexed citations

14.

Lee, Chia-Chung, Deh‐Ming Chang, Kuo-Feng Huang, et al.. (2013). Design, synthesis and antiproliferative evaluation of fluorenone analogs with DNA topoisomerase I inhibitory properties. Bioorganic & Medicinal Chemistry. 21(22). 7125–7133. 23 indexed citations

15.

Lee, Yu-Ru, Dah‐Shyong Yü, Tsung‐Chih Chen, et al.. (2013). New Approaches of PARP-1 Inhibitors in Human Lung Cancer Cells and Cancer Stem-Like Cells by Some Selected Anthraquinone-Derived Small Molecules. PLoS ONE. 8(2). e56284–e56284. 24 indexed citations

16.

Chen, Chun‐Liang, Deh‐Ming Chang, Tsung‐Chih Chen, et al.. (2012). Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology. European Journal of Medicinal Chemistry. 60. 29–41. 36 indexed citations

17.

Lee, Chia-Chung, Kuo-Feng Huang, Deh‐Ming Chang, et al.. (2012). Design, synthesis and evaluation of telomerase inhibitory, hTERT repressing, and anti-proliferation activities of symmetrical 1,8-disubstituted amidoanthraquinones. European Journal of Medicinal Chemistry. 50. 102–112. 24 indexed citations

18.

Lee, Chia-Chung, Kuo-Feng Huang, Pen-Yuan Lin, et al.. (2011). Synthesis, antiproliferative activities and telomerase inhibition evaluation of novel asymmetrical 1,2-disubstituted amidoanthraquinone derivatives. European Journal of Medicinal Chemistry. 47(1). 323–336. 26 indexed citations

19.

Huang, Hsu‐Shan, Tsung‐Chih Chen, Kuo-Feng Huang, et al.. (2009). Synthesis, cytotoxicity and human telomerase inhibition activities of a series of 1,2-heteroannelated anthraquinones and anthra[1,2-d]imidazole-6,11-dione homologues. Bioorganic & Medicinal Chemistry. 17(21). 7418–7428. 57 indexed citations

20.

Huang, Hsu‐Shan, et al.. (2009). NSC746364, NSC746365, and NSC746366: the spectra of cytotoxicity and molecular correlates of response to telomerase activity. Anti-Cancer Drugs. 21(2). 169–180. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact